Caxton Associates (UK)’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,808
Closed -$217K 823
2025
Q1
$217K Buy
+4,808
New +$217K 0.01% 689